Vaxcyte Inc PCVX:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/04/21 EST
23.62quote price arrow down-2.21 (-8.56%)
Volume
397,303
52 week range
17.80 - 58.48

...

Loading . . .

KEY STATS

  • Open25.66
  • Day High26.19
  • Day Low23.42
  • Prev Close23.62
  • 52 Week High58.48
  • 52 Week High Date09/23/20
  • 52 Week Low17.80
  • 52 Week Low Date06/12/20
  • Market Cap1,203.44M
  • Shares Out50.95M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-2.96
  • P/E (TTM)-7.99
  • Fwd P/E (NTM)-43.74
  • EBITDA (MRQ)-75.42M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Vaxcyte Inc News

There is no recent news for this security.

Latest PCVX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Vaxcyte Inc. is a vaccine company. The Company is focused on developing vaccines designed to prevent or treat common and deadly infectious diseases worldwide. Its cell-free protein synthesis platform enables it to design and produce protein carriers and antigens. Its pipeline includes pneumococcal conjugate vaccine (PCV) candidates. Its lead vaccine candidate is VAX-24, a 24-valent investigational PCV. Its pipeline also includes VAX-XP, VAX-A1 and VAX-PG. The Company's second...
Moncef Slaoui Ph.D.
Chairman
Grant Pickering
Chief Executive Officer
Andrew Guggenhime
President
Jim Wassil
Chief Operating Officer
Jane Wright-Mitchell Pharm.D.
General Counsel
Address
353 Hatch Dr
Foster City, CA
94404
United States